LOVAFARMA
ActiveSummary
LOVAFARMA has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €903,035 and a net result of €411,577. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 69% of 22,153 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
28-01
Gazette deed
Registered officeRegistered-office move2 facts ▸
- General meeting, 13-01-2025
- Registered-office move, Diestsesteenweg 133a bus 0101,3010 Leuven
10-01
Gazette deed
Appointment: L&S, Bedrijfsrevisoren BV (deskundige)Auditor report · Declaration · Capital increase11 facts ▸
- General meeting, 13-12-2024
- Auditor appointment, L&S, Bedrijfsrevisoren BV (deskundige)
- Auditor report, 12-12-2024
- Other provision, 25-04-2019
- Declaration, “geen aandelen toegekend”, 0 (deed in Dutch)
- Capital increase, €210,000
- Capital contribution, €210,000 (2 times)
- Power of attorney, ACCBEL BV
- Other provision, “section headings” (deed in Dutch)
- Other provision, “Letterlijke weergave van de besluiten van het verslag” (deed in Dutch)
- Other provision, “unanimous decision, alle besluiten genomen met éénparigheid van stemmen” (deed in Dutch)
Show earlier events
About the unread acts
Of the 5 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.